FDA Drug Application (021746) for SURFAXIN by WINDTREE THERAP

Back to FDA Applications sponsored by WINDTREE THERAP

Application Number021746
Product Number001
FormSUSPENSION;INTRATRACHEAL
Dosage8.5ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSURFAXIN
Active IngredientLUCINACTANT



Back to FDA Applications sponsored by WINDTREE THERAP